ArticlemAbs

Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19.

Thomas J Esparza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.